Home › Funds › Soleus Capital Management, L.P. › ETON
Soleus Capital Management, L.P. position in ETON
ETON PHARMACEUTICALS INC · Health Care
Soleus Capital Management, L.P. reported holding 308,101 shares of ETON (ETON PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$15.9M, representing 0.56% of its reported portfolio and ranking #43 among its reported holdings. Soleus Capital Management, L.P. has disclosed ETON holdings in 4 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Soleus Capital Management, L.P.'s ETON position evolved
Soleus Capital Management, L.P. first disclosed a stake in ETON in Q2 2025 at 285,000 shares (US$4.1M). The position peaked in Q3 2026 at 308,101 shares, worth US$15.9M. Across 4 filings, Soleus Capital Management, L.P. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 308,101 shares valued at US$15.9M. Notable position changes include a 30% trim in Q3 2025 (shares fell 22% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 285.00K | $4.06M | New |
| Q3 2025 | 200.00K | $4.35M | Reduce |
| Q1 2026 | 166.38K | $4.11M | New |
| Q3 2026 | 308.10K | $15.86M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ETON and 13F data
ETON (ETON PHARMACEUTICALS INC) is a Health Care company. 73 other funds we track also report a position in ETON — the largest reported positions include EcoR1 Capital, LLC (US$127.2M), Opaleye Management Inc. (US$103.5M), Nantahala Capital Management, LLC (US$45.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ETON
- EcoR1 Capital, LLC 2.47M sh · $127.23M · Q3 2026
- Opaleye Management Inc. 2.86M sh · $103.53M · Q2 2026
- Nantahala Capital Management, LLC 875.51K sh · $45.08M · Q3 2026
- National Philanthropic Trust 492.11K sh · $25.34M · Q3 2026
- Westside Investment Management, Inc. 401.38K sh · $20.67M · Q3 2026
- Pillsbury Lake Capital LLC 288.27K sh · $14.84M · Q3 2026
- Panoramic Capital, LLC 192.65K sh · $9.92M · Q3 2026
- Lumbard & Kellner, LLC 173.26K sh · $8.92M · Q3 2026
- Grandeur Peak Global Advisors, LLC 161.83K sh · $8.33M · Q3 2026
- Prospect Capital Advisors, LLC 145.90K sh · $7.51M · Q3 2026
- Informed Momentum Co LLC 139.21K sh · $7.17M · Q3 2026
- PRELUDE CAPITAL MANAGEMENT, LLC 97.58K sh · $5.02M · Q3 2026
More on Soleus Capital Management, L.P.
FAQ
How long has Soleus Capital Management, L.P. held ETON?
Soleus Capital Management, L.P. has disclosed ETON holdings in 4 of the last 6 reported quarters, going back to Q2 2025.
What is Soleus Capital Management, L.P.'s current position in ETON?
As of Q3 2026, Soleus Capital Management, L.P. holds 308.10K shares of ETON (ETON PHARMACEUTICALS INC), valued at $15.86M, representing 0.56% of its reported portfolio and ranking #43.
Has Soleus Capital Management, L.P. been buying or selling ETON?
In the latest 13F filing (Q3 2026), Soleus Capital Management, L.P. newly opened its position in ETON. The position peaked in Q3 2026 at 308.10K shares.
Which other funds hold ETON?
Other major institutional holders of ETON include EcoR1 Capital, LLC, Opaleye Management Inc., Nantahala Capital Management, LLC, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.